JACOBS LEVY EQUITY MANAGEMENT, INC
Position in ALDX — Aldeyra Therapeutics, Inc.
CIK 884414
FLORHAM PARK, NJ
Position in ALDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,377,769
+$31,150 QoQ
Shares Held
646,840
-18.8% QoQ
Ownership
1.07%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 108 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $741,570,791 across 81 Biotechnology names. ALDX ranks #50 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,503 | $159,939,880 | |
| 2 | RARE |
Ultragenyx Pharmaceutical Inc.
|
2,939,719 | $98,157,217 | |
| 3 | INCY |
Incyte Corp
|
731,774 | $82,953,900 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
695,532 | $60,476,507 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
322,377 | $25,232,447 | |
| 6 | EXEL |
Exelixis, Inc.
|
415,650 | $22,615,516 | |
| 7 | AUPH |
Aurinia Pharmaceuticals Inc.
|
1,231,516 | $20,898,826 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
60,986 | $18,358,615 |
All Filings in ALDX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,377,769 | 646,840 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,346,619 | 796,816 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,018,130 | 968,751 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,946,216 | 947,551 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $2,428,817 | 634,156 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $218,408 | 37,984 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $2,570,755 | 476,949 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $599,391 | 181,085 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $585,065 | 178,919 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $148,763 | 21,374 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,505,004 | 281,836 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $936,333 | 234,670 | Shares | Sole | 2022-08-15 | |
| 2021-06-30 | $487,971 | 43,069 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $511,659 | 43,069 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,043,127 | 297,832 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,266,229 | 305,834 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,272,012 | 305,039 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $111,058 | 44,963 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||